Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis-Reference-Cited by-同舟云学术

Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis

Published:1996-02 Issue:1 Volume:30 Page:29-36
ISSN:0143-4179
Container-title:Neuropeptides
language:en
Short-container-title:Neuropeptides

Author:

Alcaraz C,Vargas M.L,Milanés M.V

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Neurology,Endocrinology,General Medicine

Reference55 articles.

1. Effect of chronic methadone administration on neuroendocrine function in young adult rats;Kuhn;J. Pharmacol. Exp. Ther.,1985

2. Effects of opioids on the hypothalamo-pituitary-adrenal axis;Pechnick;Ann. Rev. Pharmacol. Toxicol.,1993

3. μ-χ-κ and ε-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: Subchronic tolerance studies of endogenous opioid peptides;Iyengar;Brain Res.,1987

4. Effects of acute and chronic administration of μ and χ-opioid agonists on the hypothalamic-pituitary-adrenocortical axis in the rat;Gonzálvez;Eur. J. Pharmacol.,1991

5. Pituitary-adrenocortical response to acute and chronic administration of U-50, 488H in the rat;Milanés;Neuropeptides,1991

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Stress, Drug Use, and Vulnerability to Addiction;Annals of the New York Academy of Sciences;2008-10

2. Enhanced Analgesia with Opioid Antagonist Administration;Journal of Palliative Medicine;2006-12

3. Stress Symptoms Induced by Repeated Morphine Withdrawal in Comparison to Other Chronic Stress Models in Mice;Neuroendocrinology;2005

4. Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors;Molecular and Cellular Neuroscience;2003-07

5. Daily injections of cyanamide enhance both ethanol-induced locomotion and brain catalase activity;Behavioural Pharmacology;1999-09